NEW YORK, Nov 15 – Aclara Biosciences third-quarter revenues inched up just one percent, while costly litigation and other expenses drove losses up sharply, the company said Wednesday.   

Aclara’s revenues for the third quarter of 2000 were $946,000, compared with $935,000 in the year-ago quarter.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.